StockNews.AI
TWST
StockNews.AI
197 days

Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results

1. Twist Bioscience announced Q1 fiscal 2025 results and business highlights. 2. The company's proprietary DNA synthesis technology is rapidly growing. 3. Twist's products impact diverse industries including healthcare and agriculture. 4. A conference call and webcast for investors is scheduled for today.

Earnings
+0.73%Current Return
VS
-0.67%S&P 500
$52.3702/03 07:33 AM EDTEvent Start
$52.7502/03 08:11 PM EDTLatest Updated
4m saved
Insight
Article

FAQ

Why Bullish?

Strong financial performance can positively influence investor sentiment. Previous earnings reports often boost stock prices.

How important is it?

Earnings announcements significantly impact stock performance and investor outlook. Growth potential and product relevance elevate company importance.

Why Short Term?

Earnings reports typically affect stock prices in the immediate future. Previous patterns show quick market reactions.

Related Companies

TWSTCRSPSNPS
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Twist Bioscience Corporation (NASDAQ: TWST), a core mid-cap growth and value equity company in the life sciences segment of the health care sector, today announced financial results and business highlights for the first quarter fiscal 2025 ended December 31, 2024. Visit the Events and Presentations page of the Investor Relations section under the “Company” tab at www.twistbioscience.com to view the detailed fiscal first quarter 2025 earnings report and the investor presentation, or click https://investors.twistbioscience.com/events-and-presentations. The company plans to hold a conference call and live audio webcast for analysts and investors at 8:00 a.m. Eastern Time today to discuss its financial results and provide an update on the company’s business. The conference call will be webcast live through the Investor Relations section under the “Company” tab at www.twistbioscience.com. Those parties interested in participating via telephone must register on the Company’s Investor Relations website or by clicking here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the call. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead of the scheduled start time. The webcast replay will be available for two weeks. About Twist Bioscience Corporation Twist Bioscience is a leading and rapidly growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to industrialize the engineering of biology. The core of the platform is a proprietary technology that pioneers a new method of manufacturing synthetic DNA by “writing” DNA on a silicon chip. Twist is leveraging its unique technology to manufacture a broad range of synthetic DNA-based products, including synthetic genes, tools for next-generation sequencing (NGS) preparation, and antibody libraries for drug discovery and development. Twist is also pursuing longer-term opportunities in digital data storage in DNA and biologics drug discovery. Twist makes products for use across many industries including healthcare, industrial chemicals, agriculture and academic research. Follow us on LinkedIn | X | YouTube | Instagram | Bluesky

Related News